TUM

Tumor Markers

Most tumor markers were built to follow a known cancer over time, not to find one. A single raised value in someone who feels well usually points somewhere harmless.

Read the Tumor Markers guide

Order a tumor marker panel hoping it will rule cancer in or out, and you are reading it close to backwards. With a few exceptions, these blood tests were never built to find cancer in a healthy person. The National Cancer Institute and MedlinePlus describe most of them as monitoring tools: their real work is following a cancer that has already been diagnosed, watching whether treatment is shrinking it and whether it later returns. Asked to screen, they do the job poorly in both directions at once.

That mismatch is what trips people up. A tumor marker can sit high in someone who is perfectly well, because ordinary conditions raise it, and it can sit normal in someone who does have cancer, because not every tumor makes much of its marker and some people cannot make certain markers at all. For neuroendocrine cancers like small cell lung cancer and neuroblastoma, the panel adds neuron-specific enolase (NSE), which can read falsely high if the sample is hemolyzed. Chromogranin A is the panel's neuroendocrine-tumor marker, and it is notorious for reading high on a common reflux drug, so see chromogranin A for why a PPI can fake an elevated result. The cards below cover each marker on its own. This page is about what the panel as a whole can and cannot do, and why the most useful thing about these numbers is the direction they move over time rather than where any one of them lands today.

Why a single high marker usually points somewhere harmless

The instinct with a flagged tumor marker is to read it as a finding. Most of the time it is closer to the opposite. MedlinePlus is direct that conditions which are not cancer can raise tumor marker levels, and that a high result only means cancer is more likely, not that it is present, with a biopsy usually needed to settle the question. The benign list is long and ordinary. CA-125 climbs with menstruation, pregnancy, endometriosis, and fibroids; CEA rises in smokers and a range of noncancer conditions; CA 19-9 is lifted by gallstones and a blocked bile duct. A modest elevation in someone with no symptoms reflects one of these far more often than a tumor.

So the panel rewards reading the number in context and over time, not reacting to the flag. The patterns below are the shapes these results tend to take, and what each usually means once the rest of the picture is in view.

The patterns and what they usually mean

One marker just over the line, and nothing else amiss

A single marker · mildly Other markers Symptoms

The most common reason people arrive worried, and among the least likely to mean cancer. MedlinePlus notes that noncancer conditions can raise tumor markers, and that a high level only signals a greater chance of cancer rather than its presence. A lone, modest elevation in someone who feels well is usually weighed against history and timing, and often simply repeated, before it carries any weight.

The same marker, measured again and again

Before treatment During treatment · falling Later draw · rising again

This is the job tumor markers were actually built for. In someone with a diagnosed cancer, MedlinePlus reads a falling marker as a sign treatment is helping and a level that climbs again as a flag for disease that has returned. The direction across serial draws carries the information; any single value in isolation carries much less.

A borderline total PSA, sorted by the free fraction

Total PSA · borderline Free PSA · high fraction

When a total PSA sits in the gray borderline zone, the free PSA percentage can tilt the reading. The American Cancer Society describes the free fraction as lower in men who turn out to have prostate cancer, so a higher free percentage leans toward benign enlargement. It refines a borderline result rather than settling it.

A normal marker that doesn't clear you

CA 19-9 AFP

A reassuring number is not the same as an all-clear. MedlinePlus notes that not every cancer raises its marker, and CA 19-9 carries an extra catch: some people are Lewis-negative, built without the antigen the marker sits on, so their result stays low whatever is happening inside. A normal AFP likewise does not rule out a liver or germ-cell tumor. The panel can miss, so a normal marker is never read as proof on its own.

If a tumor marker came back flagged

  1. 1

    Start with the doctor who ordered it

    Ask what question the test was meant to answer. Following a known cancer and investigating a symptom are different situations, and the same number reads differently in each.

  2. 2

    Give the lab the context

    Recent infections, pregnancy, smoking, gallstones, and benign enlargement can all lift a marker. MedlinePlus lists noncancer conditions among the ordinary reasons a result reads high, and they change how it is interpreted.

  3. 3

    Expect a repeat, not a verdict

    Because the trend matters more than one draw, a flagged marker is often rechecked over weeks before anyone reads much into it.

  4. 4

    Read it next to imaging and the rest of the picture

    A scan or biopsy, not the blood number, is what confirms or rules out cancer. The marker points toward a question; it does not answer it.

Why none of this is a screening test

Screening means looking for cancer before it causes symptoms, in people who feel well, and that is the use these markers are worst at. On their own, tumor markers cannot reliably detect cancer: MedlinePlus notes that the tests used for screening cannot diagnose cancer by themselves and have only a limited screening role, mostly in people already at high risk. The error runs both ways: too many false alarms in healthy people to be safe as a screen, and too many real cancers missed to be trusted as an all-clear. The National Cancer Institute frames the established value differently, as helping determine treatment, judging prognosis, and watching for recurrence in a cancer that has already been found.

This is also why the question behind the order changes everything. The same CA-125 of 50 means one thing in a premenopausal woman whose result was drawn mid-cycle and quite another in someone being followed after ovarian cancer surgery. Without that context, the number on the page is close to meaningless, which is the trap of treating any tumor marker as a standalone answer.

What the panel is actually good at

Read as a set, tumor markers reward the same habit they do one at a time: watch the trend, not the snapshot. A beta-hCG, or any other marker, means one thing climbing and another thing falling, and a single draw rarely settles a question that a second draw weeks later can. Among the breast cancer markers in this panel, CA 15-3 shows clearly why a single tumor-marker value confirms little and the trend across repeated draws is the real signal. For breast cancer specifically, CA 27-29 is followed to gauge whether treatment is working or whether the disease has returned, never to screen a healthy person. For someone under treatment, that slope is the entire point. For someone who is well, a lone flagged number is usually the start of a conversation about context and timing, not a diagnosis. The guide to reading tumor markers walks through interpreting these proteins as a moving picture, and why the same value can reassure one person and tell another almost nothing.

Sources

Written and reviewed by BloodSight Editorial Team · Last updated

Tests in this panel

Neuroendocrine

Chromogranin A

CgA

Released by neuroendocrine tissue and tracked in neuroendocrine tumors, where it helps monitor disease activity across repeated draws.

Adult Male ng/mL
0
95

Ovarian

Cancer Antigen 125

CA-125

Tied to ovarian cancer, but menstruation, pregnancy, endometriosis, and fibroids push it up as well. Most useful following a diagnosed ovarian cancer rather than searching for one.

Adult Male U/mL
0
35

Liver and germ-cell

Alpha-Fetoprotein

AFP

Alpha-fetoprotein, linked to liver cancer and germ-cell tumors. A regenerating liver from hepatitis or cirrhosis raises it too, so a mild rise rarely points cleanly at a tumor.

Adult Male ng/mL
0
10

Pancreatic and biliary

Cancer Antigen 19-9

CA 19-9

Linked to pancreatic and bile-duct cancers, and lifted by gallstones and other blockages. A notable share of people cannot produce it at all, so for them a normal result is a blind spot.

Adult Male U/mL
0
37

Breast

Cancer Antigen 15-3

CA 15-3

A breast-cancer marker the National Cancer Institute describes as a way to assess whether treatment is working or whether a cancer has returned, not as a way to find one.

Adult Male U/mL
0
30

Neuroendocrine and small-cell

Neuron-Specific Enolase

NSE

Neuron-specific enolase, tied to small-cell lung cancer and neuroendocrine tumors. Used to help judge prognosis and follow how disease responds to treatment.

Adult Male ng/mL
0
16.3

Breast

Cancer Antigen 27-29

CA 27-29

Covers much the same ground as CA 15-3 in breast cancer, followed to gauge treatment response and watch for recurrence rather than for screening.

Adult Male U/mL
0
38

Germ-cell and trophoblastic

Beta-hCG

β-hCG

Beta human chorionic gonadotropin rises in pregnancy and in choriocarcinoma and germ-cell tumors. Read as a tumor marker, it helps stage those cancers and follow their response to treatment.

Adult Male mIU/mL
0
2

Prostate, the headline

Prostate-Specific Antigen

PSA

Prostate-specific antigen, made by prostate tissue. It rises with cancer but also with benign enlargement, infection, and recent ejaculation, so it reads best as a line tracked over time rather than judged against a single cutoff.

Adult Male ng/mL
0
4

Prostate, the tie-breaker

Free PSA

The share of PSA circulating unbound. It is used to refine a borderline total PSA, where a higher free fraction leans toward benign causes rather than cancer.

Adult Male %
25
100

Colorectal, and several others

Carcinoembryonic Antigen

CEA

Carcinoembryonic antigen, tied most often to colorectal cancer but raised in other cancers, in smokers, and in some benign conditions. Used mainly to follow a known cancer and watch for recurrence.

Adult Non-smoker ng/mL
0
3

Normal ranges at a glance

Test Normal range (Adult) Unit Flagged when
Chromogranin A CgA 0–95 ng/mL < 0 or > 95
Cancer Antigen 125 CA-125 0–35 U/mL < 0 or > 35
Alpha-Fetoprotein AFP 0–10 ng/mL < 0 or > 10
Cancer Antigen 19-9 CA 19-9 0–37 U/mL < 0 or > 37
Cancer Antigen 15-3 CA 15-3 0–30 U/mL < 0 or > 30
Neuron-Specific Enolase NSE 0–16.3 ng/mL < 0 or > 16.3
Cancer Antigen 27-29 CA 27-29 0–38 U/mL < 0 or > 38
Beta-hCG β-hCG 0–2 mIU/mL < 0 or > 2
Prostate-Specific Antigen PSA 0–4 ng/mL < 0 or > 4
Free PSA 25–100 % < 25 or > 100
Carcinoembryonic Antigen CEA 0–3 ng/mL < 0 or > 3

Representative adult reference ranges; intervals vary by laboratory and method, so the range printed on your own report always takes precedence. Each test links to its full sourcing.

Tumor Markers — Common Questions

Can a tumor marker panel be used to screen me for cancer?
Generally no. MedlinePlus describes tumor marker tests as having only a limited screening role, mostly in people already at high risk, and notes that the tests used for screening cannot diagnose cancer on their own. A high level only means cancer is more likely; a biopsy is usually what confirms or rules it out. For most people with no symptoms and no known cancer, these are not the right tool to answer the question they are most often asked to answer.
My tumor marker is slightly high but I feel fine. Do I have cancer?
A mild elevation on its own is far more often benign than cancer. MedlinePlus is explicit that conditions which are not cancer can raise tumor marker levels, and many of those conditions are common: infection, inflammation, smoking, pregnancy, gallstones, and benign enlargement among them. A lone, modest result in someone without symptoms is usually read against your history and timing, and often simply repeated, before it means anything. What it means for you is a conversation with the doctor who ordered it.
Can I have cancer even though my tumor markers are normal?
Yes. MedlinePlus notes that not every cancer raises a tumor marker, so early or marker-poor tumors can sit under the cutoff. CA 19-9 carries an added catch: some people are simply built without the molecular scaffold it sits on, so their level stays low whatever is happening inside them. A normal AFP likewise does not exclude a liver or germ-cell tumor. A reassuring number is information, not an all-clear.
What are tumor markers actually used for?
Their established work is monitoring. The National Cancer Institute lists determining treatment, judging prognosis, and watching for recurrence as the main uses, and MedlinePlus describes a falling marker during treatment as a sign that it is helping. In someone with a diagnosed cancer, the trend across repeated draws is what carries the information, which is the situation these tests were designed for.
Why does my doctor keep repeating the same tumor marker test?
Because the direction matters more than any single value. A marker that falls after treatment suggests the cancer is responding, while one that climbs again can flag a return, per MedlinePlus. One draw is a snapshot and easily misread; a series of them shows the slope. That is why a flagged result is often rechecked over weeks rather than acted on the first time it appears.
How are PSA, CEA, CA-125 and the other markers different from each other?
Each is tied to particular tissues. PSA tracks the prostate, CEA leans toward colorectal and several other cancers, AFP toward liver and germ-cell tumors, CA-125 toward ovarian cancer, CA 19-9 toward the pancreas and bile ducts, CA 15-3 and CA 27-29 toward breast cancer, beta-hCG toward germ-cell and trophoblastic tumors, and NSE and chromogranin A toward neuroendocrine disease. They share the same caveat: each describes a tissue's activity, not a diagnosis.

Related panels

LIV

Liver Function Panel
HRM

Hormone Panel

Disclaimer

This content is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendation. Reference ranges may vary by laboratory. Always discuss your results with a qualified healthcare professional.